Scientists find marker that signals better brain cancer survival for children
Scientists supported by Cancer Research UK and the Samantha Dickson Research
Trust have uncovered a protein that signals a more favourable survival for
children with a form of childhood brain tumour, reveals a study published
today (Friday 28th October) in the Journal of Clinical Oncology.
Gene increases risk in breast cancer families
Close relatives of women who have had cancer in both breasts and also carry
a faulty version of the CHEK2 gene have a greatly increased risk of breast
cancer - according to a report in the Lancet.
Renowned scientist appointed to head top UK cancer labs
Dr John Diffley has been appointed as the new Director of Cancer Research
UKs London Research Institute Clare Hall Laboratories.
Everybody have listened the word Mesothelioma, but few people know what this
rare type of cancer really is. Through a series of articles you will know
and learn rapidly about this cancer disease that affects either men or women
at any age.
The cancer of the mesothelium appears when the cells of this membrane -that
forms the lining of several internal organs within the different body cavities:
the pleura in the thoracal cavity, the peritoneum in the abdominal cavity
and the pericardium in the heart sac, become abnormal or malignant
and divide neither with control nor order.
The mesothelium is composed by two layers of cells, which produce a fluid
that enable the expanding and contracting movements of organs, such as the
heart beating and the corresponding lungs movements.
Although most Mesothelioma cases start in the pleura or peritoneum, the problem
increases when these cancerous cells can damage nearby tissues and organs
or even metastasize or spread to other parts of your body.
Despite Mesothelioma cancer rate has increased over the past 20 years, this
disease is not as common as other types of cancer pathology. The number of
new diagnosed cases in the United States rises up to 2,000 per year.
Next Article: Risk factors for Mesothelioma
Article written by the staff of mesothelioma -10.com a website edited by
Hector Milla. If you want to read more articles about
malignant mesothelioma
cancer information visit
http://www.mesothelioma-10.com,
you can reprint this article in your website or ezine always mentioning the
author above and keeping a live link to his website.
DISCLAIMER
- Please note that all articles on this web site does not constitute
professional advice. All articles are intended to provide a general view
of many topical subjects from a variety of sources. We are not responsible
for the content or any sponsored links that you may choose to visit from
this web site. We suggest you to consult a solicitor and your doctor for
advice relevant to you own situation before making any important decisions.
The author is not an expert in any given field. By printing, downloading,
or using you agree to our full terms. Below is a summary of some of the terms.
If you do not agree to the full terms, do not use the information. We are
only publishers of this material, not authors. Information may have errors
or be outdated. Some information is from historical sources or represents
opinions of the author. It is for research purposes only. The information
is "AS IS", "WITH ALL FAULTS". User assumes all risk of use, damage, or injury.
You agree that we have no liability for any damages. We are not liable for
any consequential, incidental, indirect, or special damages. You indemnify
us for claims caused by you.